Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vera Zingler"'
Autor:
Jelle Praet, Lina Anderhalten, Giancarlo Comi, Dana Horakova, Tjalf Ziemssen, Patrick Vermersch, Carsten Lukas, Koen van Leemput, Marjan Steppe, Cristina Aguilera, Ella Maria Kadas, Alexis Bertrand, Jean van Rampelbergh, Erik de Boer, Vera Zingler, Dirk Smeets, Annemie Ribbens, Friedemann Paul
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system resulting in progressive disability accumulation. As there is no cure available yet for MS, the primary therapeutic objective is to reduce relapses and to
Externí odkaz:
https://doaj.org/article/80b9b6d1dce24d1e8a507b6f0114ba9f
Autor:
Petra Dirks, Vera Zingler, Jost Leemhuis, Heike Berthold, Stefanie Hieke-Schulz, David Wormser, Tjalf Ziemssen
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Multiple sclerosis (MS) is a chronic disease that requires lifelong treatment. A highly effective drug not only for relapsing but also for progressive forms of MS with a favorable safety profile is needed to further improve overal
Externí odkaz:
https://doaj.org/article/d8e9e8de57af437a984b0d10fb418cba
Autor:
Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen, Ralf A. Linker
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: With a large array of disease modifying therapies (DMTs) for relapsing-remitting MS (RRMS), identifying the optimal treatment option for the individual patient is challenging and switching of immunotherapies is often required. The objecti
Externí odkaz:
https://doaj.org/article/0fd09a02da39460790244fd7336013fa
Autor:
Tjalf Ziemssen, Vera Zingler, Petra Dirks, Boris Addow, Jelle Praet, Annemie Ribbens, Dirk Smeets, Stephen Krieger
Publikováno v:
Sunday, April 23.
Autor:
David Wormser, Jost Leemhuis, Stefanie Hieke-Schulz, Vera Zingler, Tjalf Ziemssen, Petra Dirks, Heike Berthold
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Neurology
BMC Neurology
Background Multiple sclerosis (MS) is a chronic disease that requires lifelong treatment. A highly effective drug not only for relapsing but also for progressive forms of MS with a favorable safety profile is needed to further improve overall patient
Autor:
Arndt Manzel, Ralf A. Linker, Eckard Oehm, Julia A. Kandenwein, Mathias Mäurer, Stefanie Hieke-Schulz, Tjalf Ziemssen, Patrick Oschmann, Klaus Tiel-Wilck, Vera Zingler, Michael William Springer, Nils Richter
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders
Background: With a large array of disease modifying therapies (DMTs) for relapsing-remitting MS (RRMS), identifying the optimal treatment option for the individual patient is challenging and switching of immunotherapies is often required. The objecti